At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 502 enrolled
Drug / intervention
Active +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
In Brief
A Phase 3 clinical trial evaluating Active and Vehicle for Common Wart. Completed, enrolled 502 participants across 24 sites.
Detailed Summary
Phase 3 Study of A-101 Topical Solution in Subjects with Common Warts
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCommon Wart
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
Enrollment StartSep 2018
First PostedOct 2018
Primary CompletionApr 2019
Study CompletionJul 2019
TodayJul 2026
First PostedOct 2, 2018
Enrollment StartSep 13, 2018
Primary CompletionApr 21, 2019
Study CompletionJul 9, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.8 years ago
Interventions
Activedrug
A-101 45% (hydrogen peroxide 45% topical solution)
Vehicleother
Vehicle solution containing isopropyl alcohol and water